Obesity Clinical Trial
Official title:
Prevalence and Impact of Chronic Oedema in a Population of Patients Prior to and Following Bariatric Surgery
Persistent swelling (chronic oedema), e.g. of the legs, is quite a common condition, which
can cause a number of problems, including infections (cellulitis) in the swollen area and
ulceration. It seems to be particularly common in people who are overweight but this has not
been studied in detail. This study aims to address this gap in knowledge. It will take place
in two stages, running in parallel to each other with different groups of patients. The first
stage will determine how common persistent swelling is among patients attending weight
management services at the Royal Derby Hospital and how it impacts on every day life. The
second stage will determine whether weight loss surgery improves the swelling.
The results will inform future treatment guidelines for overweight patients who have
swelling. They will also inform the design of future research that will investigate the
effects of weight loss surgery in more detail, for example by testing out methods of
measuring fluid changes in the legs.
All new patients attending the weight loss service will be eligible to take part in the first
stage of the study, as long as they: give their informed consent to take part, and can speak
English (or have someone with them who speaks English). Participants will not have had weight
loss surgery previously. The Stage 1 assessment is expected to take about 40 minutes and
consists of: a single clinical assessment for each participant to identify the presence of
the swelling and its degree in each of the affected areas and, up to 3 questionnaires
concerning their quality of life and mobility.
Patients attending the programme, who have been referred for bariatric surgery, will take
part in the second stage of the study. Stage 2 will last approximately 13 months, during
which time the participants will be assessed 4 times - once before surgery and at 3, 6, and
12-month intervals after surgery. Each Stage 2 assessment is expected to take about 50
minutes and consists of: a clinical assessment and up to 5 questionnaires.
The clinical assessments included in both stages of the study will identify the presence and
severity of swelling in each of the affected areas. Each assessment will consist of a
clinical examination of the patient's legs and abdomen to look for swelling and changes in
the skin associated with this.
Assessments carried out in Stage 1 will include bioimpedance and tissue dielectric constant
(TDC) techniques.
- Bioimpedance measures the total fluid within a limb. This test passes an extremely small
electrical current through the participant's body and measures the resistance to the
flow of this current. The participant will not feel anything when the measurement is
carried out as the current is very small, similar to the strength of a watch battery. If
the participant is able to, the test will be undertaken with the participant lying down
on an examination couch or sitting in a chair. Small stickers will be placed on the
participant's hands and feet, and clips attached to these.
- The TDC measures fluid levels at different points. In order to record these fluid
levels, a probe will be placed against the participants' skin on their feet, lower legs,
and thighs.
Assessments carried out in Stage 2 will include bioimpedance, TDC, and also perometry (or
measuring using a tape measure).
- This test measures the size and shape of the participants' legs, and can be undertaken by
one of two methods depending on their mobility. If they need to stay in a chair or
examination couch during the assessment, the size of their legs will be measured at different
points using a tape measure. However, if possible, a device called a perometer will be used.
Participants will be asked to stand with one leg in the frame of the perometer while it is
moved up and down the leg. The frame contains lights which are used to measure the size and
shape of the limb.
None of the assessments included in either stage should cause any pain or discomfort.
The questionnaires, which will be completed in both stages, concern the participants' quality
of life and mobility.
- The EQ-5D questionnaire compares quality of life over time well and can assess the
health utility of the participants. The EQ-5D scores can be used to calculate
quality-adjusted life years.
- The GAD-7 (Generalised Anxiety Disorder 7-item Scale) and PHQ-9 (Patient Health
Questionnaire - 9) questionnaires will be used to assess the anxiety/depression of the
participants. Stage 1 participants will have completed these before their study
assessments so the study team will obtain these results from their clinical records.
Stage 2 participants will complete the questionnaires as part of the study assessments.
- The SF-36 questionnaire will assess the mobility of the participants and give general
health-related quality of life scores.
- The LYMQOL questionnaire, which will only be given to participants who have oedema, is a
validated, condition-specific, quality of life instrument. It can be used both: to
assess lymphoedema of the limbs and as an outcome measure.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |